Search
for
Sort by
Research 871–900 of 1000+
- Mechanism-Based Inhibition of Human Steroid 5α-Reductase by Finasteride: Enzyme-Catalyzed Formation of NADP−Dihydrofinasteride, a Potent Bisubstrate Analog Inhibitor
- 3 percent topical minoxidil compared with placebo for the treatment of chronic severe alopecia areata.
- Morphological Features of External Genitalia in Hypospadiac Rat Model: 3-Dimensional Analysis
- Diffuse hypertrichosis during treatment with 5% topical minoxidil
- Anti-androgenic curcumin analogues as steroid 5-alpha reductase inhibitors
- A one-year observational study with minoxidil 5% solution in Germany: results of independent efficacy evaluation by physicians and patients
- Effects of 5-alpha reductase inhibitors
- Rapid onset of action of minoxidil 5% topical solution in a 4-month German observational study on both patients and physicians
- Oral Finasteride (5 mg and 2 mg) versus Topical Minoxidil 5% in Female Pattern Hair Loss
- Combination of Minoxidil 5% with Carboxytherapy versus Minoxidil 5% Alone in Treatment of Female Pattern Hair Loss
- 5. HIV, Fungal and Infectious Diseases
- Hair sheath keratins in follicular tumors. (5). Identification of hair sheath keratins in keratoacanthoma; Histopathological hair sheath structures in the tumor and their significance as differential histopathological criteria from squamous cell carcinoma.
- Comparative Study of The Effect of Topical Minoxidil 5% Versus Combined Fractional CO2 Laser and Topical Minoxidil 5% in Treatment of Male Androgenetic Alopecia
- FC 2-2 : Therapeutic Effects of Growth Factor Cocktail (CellcurinTM) containing FGF5s (fibroblast growth factor 5 short) and NMN (nicotinamide mononucleotide) applied on the scalp in the patients with androgenetic alopecia: a split study
- Effect of iontophoresis with growth factor cocktail containing fibroblast growth factor 5-short applied to the scalp in patients with androgenetic alopecia – A split study
- Synthesis and 5α-Reductase Inhibitory Activity of C21 Steroids Having 1,4-diene or 4,6-diene 20-ones and 4-Azasteroid 20-Oximes
- Characteristics of Hypertrichosis Induced by 24-week Low-dose (5 mg Daily) Oral Minoxidil in Male Pattern Hair Loss Treatment
- Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3α-androstanediol and 17β-estradiol
- Alopecia Areata Increases the Risk of Stroke: a 3-year Follow-Up Study
- Genetic ablation of myelin protein zero-like 3 in mice increases energy expenditure, improves glycemic control, and reduces hepatic lipid synthesis
- Kinetic analysis of LY320236: competitive inhibitor of type I and non-competitive inhibitor of type II human steroid 5α-reductase
- Subjects with mild alopecia benefit from aminexil clinical 5: results of a large international observational study
- News Review: Lipid Technology 5/2014
- Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- New hyaluronan-based biomatrix for 3-D follicle culture yields functionally competent oocytes
- T07-O-05 Finasteride 5 mg and sexual side effects. How many of these are related to a nocebo phenomenon?
- Finasteride reduces serum PSA to a similar extent at 1 mg and 5 mg daily doses
- Genetic Analysis of Male Pattern Baldness and the 5α-Reductase Genes
- Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review
- Clinical and hormonal effects of the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism